Found: 10
Select item for more details and to access through your institution.
Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment.
- Published in:
- PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0193048
- By:
- Publication type:
- Article
Biomarker MET in der Tumorpathologie.
- Published in:
- Die Pathologie, 2023, v. 44, n. 3, p. 193, doi. 10.1007/s00292-023-01189-2
- By:
- Publication type:
- Article
miRNA-221 and miRNA-222 induce apoptosis via the KIT/AKT signalling pathway in gastrointestinal stromal tumours.
- Published in:
- Molecular Oncology, 2015, v. 9, n. 7, p. 1421, doi. 10.1016/j.molonc.2015.03.013
- By:
- Publication type:
- Article
HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat.
- Published in:
- Journal of Pathology: Clinical Research, 2016, v. 2, n. 2, p. 59, doi. 10.1002/cjp2.35
- By:
- Publication type:
- Article
Comparison of Pre-Analytical FFPE Sample Preparation Methods and Their Impact on Massively Parallel Sequencing in Routine Diagnostics.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0104566
- By:
- Publication type:
- Article
Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-13
- By:
- Publication type:
- Article
Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Overview of Molecular Detection Technologies for MET in Lung Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2932, doi. 10.3390/cancers15112932
- By:
- Publication type:
- Article
Massively parallel sequencing fails to detect minor resistant subclones in tissue samples prior to tyrosine kinase inhibitor therapy.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1311-0
- By:
- Publication type:
- Article
Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors.
- Published in:
- 2020
- By:
- Publication type:
- journal article